Recurrence after treatment for pulmonary multidrug-resistant tuberculosis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 20687835.
- Also identified by DOI 10.1086/655892.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We estimated the proportion of recurrence within 2 years among adults cured by individualized multidrug-resistant tuberculosis regimens in Peru. Among 310 individuals with at least 24 months of follow-up, 16 experienced an episode of recurrent tuberculosis. If we assume the worst for treatment effectiveness-that all 16 episodes were caused by the original tuberculosis strain-then 5.2% (95% confidence interval, 3.0%-8.2%) experienced true relapse. This is an upper-bound estimate of relapse on which new regimens must improve.
Medical subject headings
- Tuberculosis, Multidrug-Resistant